174 related articles for article (PubMed ID: 22446359)
1. Magnetic resonance imaging of the breast in evaluating residual diseases at lumpectomy site soon after excisional biopsy.
Yang H; Liu H; Peng W; Hua Y
J Comput Assist Tomogr; 2012; 36(2):196-9. PubMed ID: 22446359
[TBL] [Abstract][Full Text] [Related]
2. Postexcisional breast magnetic resonance imaging in patients with breast cancer: predictable findings of residual cancer.
Kim JA; Son EJ; Kim EK; Kim MJ; Kwak JY; Jeong J
J Comput Assist Tomogr; 2009; 33(6):940-5. PubMed ID: 19940664
[TBL] [Abstract][Full Text] [Related]
3. Utility of breast MRI for evaluation of residual disease following excisional biopsy.
Wilkinson J; Appleton CM; Margenthaler JA
J Surg Res; 2011 Oct; 170(2):233-9. PubMed ID: 21550064
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging.
Frei KA; Kinkel K; Bonel HM; Lu Y; Esserman LJ; Hylton NM
AJR Am J Roentgenol; 2000 Dec; 175(6):1577-84. PubMed ID: 11090379
[TBL] [Abstract][Full Text] [Related]
5. Does magnetic resonance imaging accurately predict residual disease in breast cancer?
Stucky CC; McLaughlin SA; Dueck AC; Gray RJ; Giurescu ME; Carpenter SG; Grimsby GM; Apsey HA; Pockaj BA
Am J Surg; 2009 Oct; 198(4):547-52. PubMed ID: 19800466
[TBL] [Abstract][Full Text] [Related]
6. MRI before reexcision surgery in patients with breast cancer.
Lee JM; Orel SG; Czerniecki BJ; Solin LJ; Schnall MD
AJR Am J Roentgenol; 2004 Feb; 182(2):473-80. PubMed ID: 14736685
[TBL] [Abstract][Full Text] [Related]
7. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
Valdes EK; Boolbol SK; Cohen JM; Feldman SM
Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
[TBL] [Abstract][Full Text] [Related]
8. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of residual disease using breast MRI after excisional biopsy for breast cancer.
Chae EY; Cha JH; Kim HH; Shin HJ; Kim H; Lee J; Cheung JY
AJR Am J Roentgenol; 2013 May; 200(5):1167-73. PubMed ID: 23617506
[TBL] [Abstract][Full Text] [Related]
10. Discordance between pathologic and radiologic tumor size on breast MRI may contribute to increased re-excision rates.
Vanderwalde LH; Dang CM; Bresee C; Phillips EH
Am Surg; 2011 Oct; 77(10):1361-3. PubMed ID: 22127089
[TBL] [Abstract][Full Text] [Related]
11. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.
Strigel RM; Eby PR; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2010 Sep; 195(3):792-8. PubMed ID: 20729462
[TBL] [Abstract][Full Text] [Related]
12. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
[TBL] [Abstract][Full Text] [Related]
13. Complete excision of the MRI target lesion at MRI-guided vacuum-assisted biopsy of breast cancer.
Lee JM; Kaplan JB; Murray MP; Liberman L
AJR Am J Roentgenol; 2008 Oct; 191(4):1198-202. PubMed ID: 18806165
[TBL] [Abstract][Full Text] [Related]
14. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
[TBL] [Abstract][Full Text] [Related]
15. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
Smitt MC; Horst K
Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
[TBL] [Abstract][Full Text] [Related]
16. Role of pre-surgical breast MRI in the management of invasive breast carcinoma.
Del Frate C; Borghese L; Cedolini C; Bestagno A; Puglisi F; Isola M; Soldano F; Bazzocchi M
Breast; 2007 Oct; 16(5):469-81. PubMed ID: 17433681
[TBL] [Abstract][Full Text] [Related]
17. High cancer yield and positive predictive value: outcomes at a center routinely using preoperative breast MRI for staging.
Gutierrez RL; DeMartini WB; Silbergeld JJ; Eby PR; Peacock S; Javid SH; Lehman CD
AJR Am J Roentgenol; 2011 Jan; 196(1):W93-9. PubMed ID: 21178040
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma.
Scopa CD; Aroukatos P; Tsamandas AC; Aletra C
Breast J; 2006; 12(2):150-3. PubMed ID: 16509840
[TBL] [Abstract][Full Text] [Related]
19. Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast.
Biglia N; Bounous VE; Martincich L; Panuccio E; Liberale V; Ottino L; Ponzone R; Sismondi P
Eur J Surg Oncol; 2011 Mar; 37(3):199-204. PubMed ID: 21237612
[TBL] [Abstract][Full Text] [Related]
20. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]